Sexual Health

Both platelet-rich plasma (PRP) injections and low-intensity shockwave therapy (Li-ESWT) produce statistically measurable improvements in erectile function scores—but neither has cleared the bar required for guideline-endorsed treatment, and neither is FDA-approved for erectile…

Viagra (sildenafil) remains the clear first-line choice for most men with erectile dysfunction — guideline-endorsed, fast-acting, and backed by decades of randomized trial data.

Daily tadalafil at 5 mg produces modestly higher rates of successful intercourse than on-demand dosing and is the only PDE5 inhibitor regimen FDA-approved for both erectile dysfunction and lower urinary tract symptoms from benign prostatic hyperplasia.

Stendra (avanafil) wins on speed; Cialis (tadalafil) wins on flexibility and cost. For most men, those two sentences settle the choice — but the details matter enough to read past them.

Sildenafil not working doesn't mean you're out of options — it often means you haven't found the right option yet. Research consistently shows that 25–35% of men report inadequate response to Viagra, but a large fraction of those are fixable with better technique, a different…

Reduced sex drive after 40 is real, common, and treatable — but the supplement industry has built a billion-dollar business on men who don't know the difference between a clinically validated intervention and a marketing claim. Here is what the evidence actually supports.

The honest answer is that no supplement stack outperforms a PDE5 inhibitor or testosterone therapy in men with documented hypogonadism — but the right nutraceutical combination can meaningfully support the men who don't (yet) need a prescription, or who want to amplify what…

The supplements with the strongest clinical evidence for male libido are Panax ginseng, saffron, L-arginine, ashwagandha, and Eurycoma longifolia — in that order of overall data quality.

Stendra (avanafil) can support successful intercourse as early as 10–15 minutes after dosing — roughly twice as fast as the standard one-hour guidance for Viagra (sildenafil).

Tadalafil lasts significantly longer than sildenafil — up to 36 hours versus 4–6 hours — and that difference comes down to a single pharmacokinetic fact: tadalafil's half-life is roughly 17.5 hours compared to sildenafil's 3–5 hours.

Both sildenafil (Viagra) and vardenafil (Levitra) reach peak plasma concentration in roughly 60 minutes under fasting conditions — but clinical stopwatch data show meaningful erections arriving well before that, often within 20–30 minutes for men who respond to either drug.

Men who have genuinely turned their health around in midlife tend to give the same advice: start with the fundamentals, get your numbers checked, then layer in targeted therapies where the evidence actually supports them.

Tadalafil (Cialis) and vardenafil (Levitra) are both proven PDE5 inhibitors, but they serve different sexual lifestyles — and choosing between them comes down to how often you have sex, whether you also have urinary symptoms, and how much you want to plan around a pill.

For daily ED therapy, Cialis (tadalafil) 2.5–5 mg once daily is the clear evidence-based choice — it's the only PDE5 inhibitor with FDA approval specifically for that indication.

The short answer: 200mg gets you a modestly higher erectile function score on paper, but the difference in whether you actually complete intercourse is statistically negligible.

Tadalafil (Cialis) has a half-life of approximately 17.5 hours, which means a single dose keeps clinically meaningful levels in your bloodstream for up to 36 hours — and sometimes closer to 48.

Two sessions a week—totaling roughly 30–60 minutes—appears to be the dose at which resistance training delivers its largest mortality benefit. Beyond that threshold, returns diminish fast; below it, you're leaving meaningful protection on the table.

Several legitimate non-prescription approaches to erectile dysfunction are backed by controlled trial data — but the gap between evidence and marketing claims is wide. Here's what the research actually supports, ranked by strength of evidence.

Low-intensity shockwave therapy (LI-ESWT) produces real, measurable improvements in erectile function for men with mild-to-moderate vasculogenic ED — but the gains are modest, durability past 12 months is uncertain, and the FDA still classifies it as investigational.

Tadalafil is the best-fit ED medication for most men over 50—but "best" depends heavily on your cardiovascular profile, other medications, and whether you want a pill you take daily or one you time around sex. Here's what the evidence actually supports.

Tadalafil wins on patient preference and flexibility; sildenafil wins on cost. Neither drug is objectively superior in raw erectile outcomes — the right choice depends on how you have sex, what you can afford, and which side effects you can tolerate.

PT-141 (bremelanotide) produces measurable improvements in sexual desire and arousal—roughly 34% of men in controlled studies report significantly improved erectile function versus 9% on placebo, and women in FDA trials gained an average of 0.7 additional satisfying sexual…

No single ED drug is universally "best"—the optimal choice depends on individual factors like onset time preferences, duration needs, side effects, and underlying health conditions. Sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra) are all effective FDA-approved options with different characteristics.

There is no single "best" ED drug for everyone—sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra) are all highly effective PDE5 inhibitors with similar success rates of 70-85%, but they differ in onset time, duration, and side effect profiles, making the optimal choice dependent on individual patient needs, lifestyle, and medical conditions.